DATO-BASE: A phase 2 trial of DATOpotamab-deruxtecan for breast cancer Brain metAstaSEs

Clinical Trial Grant

Duke Scholars

Principal Investigator Carey Kernodle Anders Medicine, Medical Oncology

Awarded By

Dana-Farber Cancer Institute

Start Date

September 5, 2024

End Date

September 14, 2029

Awarded By

Dana-Farber Cancer Institute

Start Date

September 5, 2024

End Date

September 14, 2029